SPECIFIC DELAY IN THE DEGRADATION OF MITOCHONDRIAL ATP SYNTHASE SUBUNIT C IN LATE INFANTILE NEURONAL CEROID-LIPOFUSCINOSIS IS DERIVED FROM CELLULAR PROTEOLYTIC DYSFUNCTION RATHER THAN STRUCTURAL ALTERATION OF SUBUNIT-C
J. Ezaki et al., SPECIFIC DELAY IN THE DEGRADATION OF MITOCHONDRIAL ATP SYNTHASE SUBUNIT C IN LATE INFANTILE NEURONAL CEROID-LIPOFUSCINOSIS IS DERIVED FROM CELLULAR PROTEOLYTIC DYSFUNCTION RATHER THAN STRUCTURAL ALTERATION OF SUBUNIT-C, Journal of neurochemistry, 67(4), 1996, pp. 1677-1687
Previously we indicated that a specific delay in subunit c degradation
causes the accumulation of mitochondrial ATP synthase subunit c in ly
sosomes from the cells of patients with the late infantile form of neu
ronal ceroid lipofuscinosis (NCL), To explore the mechanism of lysosom
al storage of subunit c in patient cells, we investigated the mechanis
m of the lysosomal accumulation of subunit c both in cultured normal f
ibroblasts and in in vitro cell-free incubation experiments. Addition
of pepstatin to normal fibroblasts causes the marked lysosomal accumul
ation of subunit c and less accumulation of Mn2+-superoxide dismutase
(SOD), In contrast, E-64-d stimulates greater lysosomal storage of Mn2
+-SOD than of subunit c. Incubation of mitochondrial-lysosomal fractio
ns from control and diseased cells at acidic pH leads to a much more r
apid degradation of subunit c in control cells than in diseased cells,
whereas other mitochondrial proteins, including Mn2+-SOD, beta subuni
t of ATP synthase, and subunit IV of cytochrome oxidase, are degraded
at similar rates in both control and patient cells. The proteolysis of
subunit c in normal cell extracts is inhibited markedly by pepstatin
and weakly by E-64-c, as in the cultured cell experiments. However, th
ere are no differences in the lysosomal protease levels, including the
levels of the pepstatin-sensitive aspartic protease cathepsin D betwe
en control and patient cells, The stable subunit c in mitochondrial-ly
sosomal fractions from patient cells is degraded on incubation with mi
tochondrial-lysosomal fractions from control cells. Exchange experimen
ts using radiolabeled substrates and nonlabeled proteolytic sources fr
om control and patient cells showed that proteolytic dysfunction, rath
er than structural alterations such as the posttranslational modificat
ion of subunit c, is responsible for the specific delay in the degrada
tion of subunit c in the late infantile form of NCL.